Marek Bebenek

Prof. Marek Bebenek


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2015 in Radiotherapy and Oncology
Verified
Journal Article
Closed access
VVVincenzo Valentini
Vincenzo Valentini
RSRuud G.P.M. van Stiphout
Ruud G.P.M. van Stiphout
GLGuido Lammering
Guido Lammering
MGMaria A. Gambacorta
Maria A. Gambacorta
MBMaria C. Barba
Maria C. Barba
PLPhilippe Lambin
Philippe Lambin

10 November 2025 in Cancers
Verified
Journal Article
Open access
PDF file
MKMichał Kazanowski
Michał Kazanowski
PLPaweł Lesiak
Paweł Lesiak
JWJędrzej Wierzbicki
Jędrzej Wierzbicki
BKBartosz Kapturkiewicz
Bartosz Kapturkiewicz
PMPaweł Maciejewski
Paweł Maciejewski
MBMarek Bebenek
Marek Bebenek
Background: Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) can cure selected patients with colorectal peritoneal metastases (CPM). Real-world prognostic data, especially for the Peritoneal Cancer Index (PCI) and completeness of cytoreduction (CCR), are limited. Methods: We retrospectively analysed 75 consecutive patients treated with CRS + HIPEC at a tertiary centre (2014–2022), giving ≥36 months potential follow-up. Overall survival (OS) was assessed by Kaplan–Meier and Cox models. PCI was grouped 0–10, 11–20, >20; CCR was dichotomised (CCR-0 vs. CCR 1/2). Multivariable analysis included PCI, CCR, and resection extent; HIPEC drug was examined univariately. Results: The median follow-up was 41 months. Crude 3-year OS was 50.7% (38/75). Survival decreased with higher PCI: 69% for 0–10 (n = 42), 38% for 11–20 (n = 21), and 0% for > 20 (n = 4). Versus PCI 0–10, the adjusted hazard ratios (HR) were 3.02 (95% CI 1.52–6.03) for PCI 11–20 and 7.29 (1.72–30.81) for > 20. CCR-0 improved OS univariately (HR 0.43) but was non-significant after adjustment (HR 0.89). Resection limited to the peritoneum (HR 0.99) and choice of intraperitoneal drug showed no independent effect. Conclusions: In this real-world cohort, PCI was the only independent predictor of 3-year survival after CRS + HIPEC for CPM; neither CCR status, surgical extent, nor HIPEC agent altered prognosis once PCI was considered. PCI should therefore remain the principal selection criterion while molecular and biological markers are integrated into future risk models.

4 March 2026 in Scientific Reports
Verified
Journal Article
Open access
BKBartosz Kapturkiewicz
Bartosz Kapturkiewicz
MKMichał Kazanowski
Michał Kazanowski
PLPaweł Lesiak
Paweł Lesiak
DRDavid M. Ramsey
David M. Ramsey
MBMarek Bebenek
Marek Bebenek
Anastomotic leakage remains a major complication in colorectal surgery. Although several risk factors have been identified, the specific risks associated with TaTME procedures require further clarification. The aim of this study was to determine the frequency of anastomotic leakage after TaTME and to identify factors influencing leakage rates. Out of 237 patients who underwent TaTME, 229 received an anastomosis. Seventeen were excluded from further analysis—14 due to lack of leakage assessment before ileostomy closure and 3 due to missing follow-up data—resulting in a final cohort of 212 patients. Cases were analysed with respect to anastomotic technique and other variables potentially affecting the incidence of anastomotic leakage. Data were obtained from a prospectively maintained institutional database. The mean tumour distance from the anorectal junction (ARJ) was 2.92 cm (± 1.56). Anastomotic leakage occurred in 27 patients (12.74%). The only statistically significant risk factor for leakage was the type of anastomosis: leakage occurred in 18.28% of patients with hand-sewn anastomosis and in 8.47% of those with stapled anastomosis. Tumour height indirectly influenced the leakage rate, as hand-sewn anastomosis was used predominantly in lower tumours (1.78 cm vs. 3.82 cm from the ARJ). Anastomotic leakage rates after TaTME are comparable to those reported for other rectal cancer surgical techniques. Leakage risk is primarily determined by the type of anastomosis and, indirectly, by tumour height. TaTME appears to be a feasible option for selected patients in experienced centres, although further validation is required.

6 September 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
CTCwalinski Tomasz
Cwalinski Tomasz
PKPatryk Kaczor
Patryk Kaczor
BKBartosz Kapturkiewicz
Bartosz Kapturkiewicz
MCMaciej Ciesielski
Maciej Ciesielski
MKMichał Kazanowski
Michał Kazanowski
Luigi MaranoLuigi Marano
Luigi Marano
Background: Anastomotic leak remains a major complication after colorectal cancer surgery. While most studies focus on prediction or prevention, less is known about the clinical course after leak diagnosis. We aimed to evaluate the occurrence, severity, management, and early postoperative consequences of anastomotic leak after elective colorectal cancer surgery. Methods: This retrospective multicenter cohort study included consecutive patients undergoing elective colorectal cancer resection with restoration of bowel continuity in five tertiary referral centers. Patients without an evaluable anastomosis were excluded. The primary endpoint was 30-day anastomotic leak incidence. Secondary endpoints included Clavien–Dindo severity, therapeutic management, major morbidity, surgical reintervention, length of hospital stay, intensive care unit admission, readmission, and 30-day mortality. Firth penalized logistic regression was used for adjusted analyses. Results: Among 943 patients with an evaluable anastomosis, 55 developed an anastomotic leak (5.8%). Leak was more frequent after rectal than colon cancer surgery (8.8% vs. 4.5%; crude OR 2.04, 95% CI 1.18–3.53; p = 0.016). After adjustment, rectal cancer remained independently associated with leak occurrence (adjusted OR 3.61, 95% CI 1.74–7.48; p < 0.001), whereas intraoperative indocyanine green fluorescence angiography was not (adjusted OR 1.02, 95% CI 0.48–2.17; p = 0.962). Once leak occurred, 92.7% of patients developed major morbidity, 76.4% required surgical reintervention, and, among patients with available length-of-stay data, 65.4% had a postoperative hospital stay exceeding 14 days; 30-day mortality was 10.9%. Conclusions: Anastomotic leak occurred in fewer than 6% of elective colorectal cancer resections but was associated with severe postoperative deterioration. Its impact is better captured by evaluating severity, management, and downstream consequences, rather than incidence alone.

15 February 2026 in Archives of Medical Science
Verified
Journal Article
Closed access
MKMichał Kazanowski
Michał Kazanowski
PLPaweł Lesiak
Paweł Lesiak
JWJędrzej Wierzbicki
Jędrzej Wierzbicki
BKBartosz Kapturkiewicz
Bartosz Kapturkiewicz
PMPaweł Maciejewski
Paweł Maciejewski
MBMarek Bebenek
Marek Bebenek
Introduction: Peritoneal surface malignancies (PSMs) are challenging to treat due to their locoregional nature and poor response to systemic therapies. Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) has emerged as a promising treatment for selected patients, though long-term, real-world data remain limited. Aim of the study: To analyze clinical outcomes, survival patterns, and prognostic factors in a large cohort of patients undergoing CRS-HIPEC over a 10-year period at a national referral center. Material and methods: This retrospective study included 292 adult patients who underwent 319 CRS-HIPEC procedures between 2015 and 2024. Primary endpoints included overall survival (OS) and postoperative outcomes. Data were stratified by tumor type, Peritoneal Cancer Index (PCI), and Completeness of Cytoreduction (CC-score). Results: The most common indications were colorectal cancer (34.5%), ovarian cancer (27.0%), low-grade appendiceal mucinous neoplasm (LAMN) (16.1%), primary peritoneal cancer (17.7%), and gastric cancer (3.7%). Complete cytoreduction (CC-0) was achieved in 69.9% of cases. Five-year survival rates were highest in LAMN (90.4%) and primary peritoneal cancer (80.7%), and lowest in gastric cancer (25.0%). Lower PCI (<20) and CC-0 resection were strongly associated with improved survival. Postoperative morbidity declined over time, with no in-hospital mortality since 2022. Conclusions: CRS-HIPEC offers substantial long-term survival benefits in selected patients with PSMs. Tumor biology, PCI, and completeness of cytoreduction are key prognostic factors. Our findings support expanding access to HIPEC in well-selected cases, particularly in tumors with peritoneal-confined dissemination.

31 March 2026 in Techniques in Coloproctology
Verified
Journal Article
Open access
PDF file
BKBartosz Kapturkiewicz
Bartosz Kapturkiewicz
MKMichał Kazanowski
Michał Kazanowski
PLPaweł Lesiak
Paweł Lesiak
DRDavid M. Ramsey
David M. Ramsey
MBMarek Bebenek
Marek Bebenek
Background: Transanal total mesorectal excision (TaTME) is a technically demanding procedure with a significant learning curve. Operative time is often used as a proxy for procedural proficiency. Objective: To evaluate the impact of the learning curve and selected patient- and procedure-related factors on the operative duration of TaTME procedures. Methods: A retrospective analysis was conducted on 250 consecutive patients who underwent TaTME for rectal cancer between 2016 and 2025. Operative time trends were assessed in relation to case sequence, individual surgeon experience, and patient-related variables including sex, body mass index (BMI), ASA score, and technical aspects such as protective ileostomy creation. Results: The mean operative time across the cohort was 200.52 min. A significant reduction in operative duration was observed over time, with stabilizing after approximately 100 cases. Male sex, higher BMI, and ASA scores ≥ 3 were independently associated with longer operative times. The use of a protective ileostomy also significantly increased operative duration. After adjusting for surgeon experience and case complexity, no difference remained between laparoscopic and open approaches. Substantial interoperator variability was observed, particularly in early cases. Conclusions: TaTME is associated with a steep learning curve, which significantly increases operative time. Patient-related factors such as sex, BMI, and comorbidities further influence surgical duration. These findings support the need for structured training pathways, outcome monitoring, and individualized preoperative planning.